Publication | Closed Access
BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer
12
Citations
21
References
2022
Year
Cancer ImmunosurveillancePancreatic CancerImmunologyBtla+cd200+ B CellsImmune Checkpoint InhibitorAutoimmunityImmunotherapeuticsPrimary Pancreatic CancerDivergent Immune LandscapeImmunotherapyMedicineRadiation OncologyTumor Microenvironment
| Year | Citations | |
|---|---|---|
Page 1
Page 1